NCT01970865 · Interventional trial
A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations
Overall registry status Completed
Phase 1 · Phase 2
Conditions ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory